Defactinib Completed Phase 1 Trials for Non Hematologic Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01943292Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies